Axinn Shortlisted for 2024 LMG Life Sciences Americas Awards
July 18, 2024
Axinn is pleased to announce that the firm has been shortlisted for the LMG Life Sciences Americas "Hatch-Waxman Litigation Firm of the Year – Generic" award, and IP group chair Matthew Becker has been shortlisted for the "Hatch-Waxman Litigator of the Year – Generic" award.
The LMG Life Sciences Americas Awards recognize the region’s most distinguished practitioners and their firms for their exemplary work in the life sciences legal practice over the past twelve months.
The winners will be announced at the annual awards event, which will be held in New York on September 5.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
NJSBA Annual Meeting and Convention 2025
Speaking Engagement
Intellectual Property
CompLaw Antitrust West Coast Conference 2025
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2025
Sponsorship
Antitrust
ACI 21st Annual Paragraph IV Conference
Speaking Engagement
Intellectual Property
ABA 73rd Annual Section of Antitrust Law Spring Meeting
Speaking Engagement
Antitrust
AIPLA CLE Web Series: Hot Topics in Chemical & Biotech Patent Practice
Speaking Engagement
17th Annual Practitioners' Think Tank on ITC Litigation & Enforcement
Speaking Engagement
Intellectual Property
Antitrust Enforcement Trends and Policies in 2025: Unfair Competition, Merger Policies, Premerger Procedures
Webinar
Antitrust
CompLaw Nordic 2025
Speaking Engagement
Antitrust
Compounding Problems: Recent Decisions on Tirzepatide Highlight Interplay Between FDA Anti-Compounding Enforcement and Private Intellectual Property Rights
Axinn Viewpoints
Intellectual Property